Stryker has agreed to sell its US spinal implants business to the Viscogliosi Brothers. The newly formed company will be ...

On Jan. 28, major orthopedic and spine device manufacturer Stryker announced plans to sell off its U.S. spinal implants business. Here are eight things for ASCs to know about the sale: 1. Stryker's ...

Discover the latest advancements in spine and orthopedic robotics, including the first biportal endoscopic fusion and FDA approval for Stryker.

Medtech giants are doubling down on robotic surgery systems as hospitals see fewer complications and shorter stays.

Stryker’s US spinal implants sale to VB Spine creates growth opportunities for competitors like Medtronic and Globus in the ...

Stryker Corporation’s SYK shares closed the trading session at $385.18 on Friday, 5.2% below its 52-week high of $406.19 ...

From leadership updates to FDA clearances, here are five key updates from spine and orthopedic medtech companies since Feb. 12.

Stryker Corp. plans to sell its U.S. spinal implant business to a New York-based family office Viscogliosi Brothers LLC.

Stryker reported $6.4 billion in sales and $22,595 million in operating profit for the quarter ending December 31, 2024, ...

Stryker beats Q4 estimates with $6.44B revenue and $4.01 EPS, announces CFO retirement and spine implant business sale. Analysts raise Stryker price targets, citing strong sales, margin expansion ...